Table 1 Baseline characteristics of the 1117 HIV-infected children included in the pWADA cohort, Abidjan, May-August 2012
Characteristics (N = 1117) | n (%) |
|---|---|
Centre participants, n (%) | |
Cocody University Hospital | 182 (16.3) |
Yopougon University Hospital | 344 (30.8) |
CePReF | 322 (28.8) |
CIRBA | 212 (19.0) |
MTCT+ | 57 (5.1) |
Total site | 1117 (100.0) |
Age (years) | |
Median (IQR) | 9 (6–12) |
Sex, n (%) | |
Male | 553 (49.5) |
Female | 564 (50.5) |
HIV type, n (%) | |
1 | 1111 (99.4) |
2 | 4 (0.4) |
1 & 2 | 2 (0.2) |
Last CD4 measurement available at the time of the visit | |
Percentage when age < 5 years n (%) | 144 (13.0) |
Median CD4 % (IQR) | 29 (24–35) |
CD4 > 35 %, n (%) | 34 (23.6) |
25 % ≤ CD4 ≤ 35 %, n (%) | 66 (45.8) |
CD4 < 25 %, n (%) | 40 (27.8) |
Missing, n (%) | 4 (2.8) |
Cell count when age ≥ 5 years n (%) | 973 (87.0) |
Median CD4 cells/mm3, (IQR) | 781 (507–1084) |
CD4 > 500 cells/mm3, n (%) | 731 (75.1) |
350 ≤ CD4 ≤ 500 cells/mm3, n (%) | 102 (10.5) |
CD4 < 350 cells/mm3, n (%) | 140 (14.4) |
Missing, n (%) | 0 (0.0) |
Treatment received at the time of the visit | |
On ART – On Cotrimoxazole | 667 (59.7) |
Off ART – On Cotrimoxazole | 83 (7.4) |
On ART – Off Cotrimoxazole | 323 (29.0) |
Off ART – Off Cotrimoxazole | 35 (3.1) |
On ART unknown for Cotrimoxazole | 9 (0.8) |
ART drugs regimen | |
2 NRTIa + 1 NNRTIb | 842 (84.3) |
2 NRTI + 1 PIc | 144 (14.4) |
3 NRTI | 9 (0.9) |
Missing | 4 (0.4) |
Median follow-up time on ART (year) (IQR) | 2.2 (0.4-5.2) |
Median follow-up time on Cotrimoxazole (year) (IQR) | 3.4 (1.3-6.1) |